A survey on the clinical practice and the guidelines for sexually transmitted infections in Korea

Hyun-Sop Choe; Seung-Ju Lee; Dong Hoon Lim; Yong-Hyun Cho; Chul Sung Kim

doi:10.5124/jkma.2010.53.11.1028

Journal List > J Korean Med Assoc > v.53(11) > 1042221

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Choe, Lee, Lim, Cho, and Kim: A survey on the clinical practice and the guidelines for sexually transmitted infections in Korea

Original Article

Journal of the Korean Medical Association

Journal of the Korean Medical Association 2010; 53(11): 1028-1036.

Published online: 15 November 2010

DOI: https://doi.org/10.5124/jkma.2010.53.11.1028

A survey on the clinical practice and the guidelines for sexually transmitted infections in Korea

Hyun-Sop Choe, MD¹, Seung-Ju Lee, MD¹, Dong Hoon Lim, MD², Yong-Hyun Cho, MD³, Chul Sung Kim, MD²

¹Department of Urology, The Catholic University of Korea, St. Vincent's Hospital, Suwon, Korea.

²Department of Urology, Chosun University College of Medicine, Gwangju, Korea.

³Department of Urology, The Catholic University of Korea, St. Mary's Hospital, Seoul, Korea.

Corresponding author: Chul Sung Kim, cskim@chosun.ac.kr

Received 23 July 2010 Accepted 13 September 2010

(open-access):

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Every year 150 million new cases of sexually transmitted infection are expected to occur around the world with high occurrence and morbidity rates in both males and females. To respond to dramatically changing social and cultural environments, clinical treatment guidelines for diagnosis, treatment, and prevention of sexually transmitted infections have been developed in many countries, and South Korea has also prepared treatment guidelines which can be used in medical institutions treating primarily these diseases. Against this background, this study conducted a 31-item questionnaire survey by mail and e-mail to investigate the actual clinical practices of physicians treating sexually transmitted infections. In total, 250 and 1,068 questionnaires were distributed through mail and e-mail, respectively, and 274 of them were completed and returned for a response rate of 20.8%. According to the results, physicians' actual clinical practices were found to be different from textbook guidelines to some degree. Therefore, treatment guidelines that take into account the current situation for sexually transmitted infections should be developed in Korea, and a foundation for national management of the diseases should be established through active advertisements.

Keywords: Sexually transmitted infection, Guideline, Questionnaire survey

Figures and Tables

Table 1

Characteristics of participants (n=274)

Table 2

Preference on the guidelines of STIs

STI, sexually transmitted infection; KCDC, Korea Centers for Disease Control and Prevention; CDC, Centers for Disease Control and Prevention

Table 3

Preference on the syphilis

VDRL, venerial disease research laboratory slide test; RPR, rapid Plasma Reagin test; TPHA, Treponema Pallidum Haemagglutination Assay; FTA-ABS, fluorescent treponema antibody-absorption test; Sx., symptom; IM, intramuscular; IV, intravenous

Table 4

Preference on the urethritis or cervicitis

NAAT, nucleic acid amplification test; PCR, polymerase chain reaction; SDA, strand displacement amplification; TMA, transcription mediated amplification

Table 5

Preference on the gonococcal and non-gonococcal infection

IM, intramuscular; IV, intravenous; PO, per os (by mouth)

Table 6

Preference on the urethritis or cervicitis

STI, sexually transmitted infection; PO, per os (by mouth)

Table 7

Preference on the prevention of STIs

STI, sexually transmitted infection

References

1. Guidelines for management of sexually transmitted infection [Internet]. 2008. cited 2009 June 15. Seoul: Korean Center for Disease Control and Prevention;Available from: http://www.cdc.go.kr/kcdchome/FileDownload.do?file=/board/582/2008081917574734_20904_0.hwp.

2. Workowski KA, Berman SM. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006. 55:1–94.

3. Ratnam S. The laboratory diagnosis of syphilis. Can J Infect Dis Med Microbiol. 2005. 16:45–51.

4. Lukehart SA. Serologic testing after therapy for syphilis: is there a test for cure? Ann Intern Med. 1991. 114:1057–1058.

5. Elliott WC. Treatment of primary syphilis. J Am Vener Dis Assoc. 1976. 3(2 Pt 2):128–135.

6. Idsoe O, Guthe T, Willcox RR. Penicillin in the treatment of syphilis: the experience of three decades. Bull World Health Organ. 1972. 47:Suppl. 1–68.

7. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, Bolan G, Johnson SC, French P, Steen E, Radolf JD, Larsen S. The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med. 1997. 337:307–314.

8. Gaydos CA, Quinn TC. Urine nucleic acid amplification tests for the diagnosis of sexually transmitted infections in clinical practice. Curr Opin Infect Dis. 2005. 18:55–66.

9. Bloomfield PJ, Steiner KC, Kent CK, Klausner JD. Repeat chlamydia screening by mail, San Francisco. Sex Transm Infect. 2003. 79:28–30.

10. Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, Steece R, Markowitz LE, Devine OJ, Walsh CM, Wang S, Gunter DC, Irwin KL, DeLisle S, Berman SM. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002. MMWR Recomm Rep. 2002. 51:1–38.

11. Tapsall JW, Limnios EA, Abu Bakar HM, Darussalam B, Ping YY, Buadromo EM, Kumar P, Singh S, Lo J, Bala M, Risbud A, Deguchi T, Tanaka M, Watanabe Y, Lee K, Chong Y, Noikaseumsy S, Phouthavane T, Sam IC, Tundev O, Lwin KM, Eh PH, Goarant C, Goursaud R, Bathgate T, Brokenshire M, Latorre L, Velemu E, Carlos C, Leano S, Telan EO, Goh SS, Koh ST, Ngan C, Tan AL, Mananwatte S, Piyanoot N, Lokpichat S, Sirivongranson P, Fakahau M, Sitanilei H, Hung le V. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions 2007-2008. Commun Dis Intell. 2010. 34:1–7.

12. Yong D, Kim TS, Choi JR, Yum JH, Lee K, Chong Y, Oh HB, Shultz T, Tapsall JW. Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries. J Antimicrob Chemother. 2004. 54:451–455.

13. Yoo J, Yoo C, Cho Y, Park H, Oh HB, Seong WK. Antimicrobial resistance patterns (1999-2002) and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea. Sex Transm Dis. 2004. 31:305–310.

14. Bodsworth NJ, Crooks RJ, Borelli S, Vejlsgaard G, Paavonen J, Worm AM, Uexkull N, Esmann J, Strand A, Ingamells AJ, Gibb A. International Valaciclovir HSV Study Group. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. Genitourin Med. 1997. 73:110–116.

15. Chosidow O, Drouault Y, Leconte-Veyriac F, Aymard M, Ortonne JP, Pouget F, Revuz J, Decazes JM, Malkin JE. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial. Br J Dermatol. 2001. 144:818–824.

16. Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. The Valaciclovir International Herpes Simplex Virus Study Group. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. Sex Transm Dis. 1997. 24:481–486.

17. Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Collaborative Famciclovir Genital Herpes Research Group. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. JAMA. 1998. 280:887–892.

18. Gross G, Ikenberg H, Gissmann L, Hagedorn M. Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol. 1985. 85:147–152.

19. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001. 164:1017–1025.

20. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988. 10:122–163.

21. Chuang TY, Perry HO, Kurland LT, Ilstrup DM. Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features. Arch Dermatol. 1984. 120:469–475.

22. Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk RD, Cu-Uvin S, Duerr A, Greenblatt RM, Klein RS, Massad S, Minkoff H, Muderspach L, Palefsky J, Piessens E, Schuman P, Watts H, Shah KV. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis. 2002. 29:427–435.

23. Simmons PD, Langlet F, Thin RN. Cryotherapy versus electrocautery in the treatment of genital warts. Br J Vener Dis. 1981. 57:273–274.

24. Abdullah AN, Walzman M, Wade A. Treatment of external genital warts comparing cryotherapy (liquid nitrogen) and trichloroacetic acid. Sex Transm Dis. 1993. 20:344–345.

25. Tyring SK, Arany I, Stanley MA, Tomai MA, Miller RL, Smith MH, McDermott DJ, Slade HB. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis. 1998. 178:551–555.

26. Kirby P, Dunne A, King DH, Corey L. Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts. Am J Med. 1990. 88:465–469.

TOOLS

Similar articles